Platelet derivatives in regenerative medicine: an update

Area of Science:

• Regenerative Medicine
• Biomaterials Science

Background:

• Platelet-derived products leverage autocrine and paracrine biomolecules from alpha granules for tissue healing.
• Growth factors and cytokines in platelets orchestrate inflammation, collagen synthesis, granulation, and angiogenesis.

Purpose of the Study:

• To review the current applications of platelet-derived biological products.
• To examine the rationale and preparation requirements for these regenerative therapies.
• To address the variability in therapeutic efficacy and ongoing research.

Main Methods:

• Review of preclinical and clinical studies on platelet-derived products.
• Analysis of various platelet derivatives: platelet-rich plasma, gel, fibrin, and eye drops.
• Examination of published data on bone density, joint regeneration, and wound healing.

Main Results:

• Individual studies report favorable effects in dentistry, joint regeneration, and wound healing.
• Inconsistent clinical benefits observed in some randomized controlled trials and meta-analyses.
• Significant variability in product structure, composition, and cytokine concentrations noted.

Conclusions:

• Standardized preparation protocols are crucial for reproducible therapeutic outcomes.
• Ongoing large-scale, phase 3/4 clinical trials are essential to definitively assess efficacy.
• The therapeutic rationale for platelet-derived compounds requires further elucidation through robust clinical evidence.